Phase 3 Alzheimer's Disease Trial, Not Yet Recruiting NCT06797817 Sponsor: Universidad de Almeria Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 3 Alzheimer's Disease Trial, Not Yet Recruiting

NCT06797817
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with mild Alzheimer's disease within the past year.
  • People who are willing to give their consent to take part in the study, in line with internationally recognised ethical guidelines for research.
  • People who are not currently taking part in another clinical trial that could affect the results of this study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have other possible causes of dementia, such as a history of severe head injury, brain tumours, epilepsy, or infections affecting the brain or nervous system.
  • People who are using treatments that could interfere with the trial, including immune-suppressing drugs, steroids, antibiotics, or who have received chemotherapy in the month before the trial begins.
  • People who have disorders affecting the digestive system (such as the stomach or intestines).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 August 2026

Contact this trial

Phone: 0034950214563

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Universidad de Almeria
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Montreal Cognitive Assessment (MoCA)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov